Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chen, Yu Jen ^a,b,c   Chen, Ying Yin ^d   Lin, Yi Feng ^d   Hu, Hsuan Yun ^d   Liao, Hui Fen ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; BETA CATENIN; GELATINASE B; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; RESVERATROL; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; GRAPE; MEDICINAL PLANT; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84878726261     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/632121     Document Type: Article

References (35)

1. Ghattas S., Howle J., Wang W., Kefford R., Gruenewald S., Intravascular metastatic melanoma: a difficult diagnosis. Australasian Journal of Dermatology 2013 54 2 141 143 10.1111/ajd.12033
2. Wangari-Talbot J., Chen S., Genetics of melanoma. Frontiers in Genetics 2012 3 330
3. Kim D. S., Jeong Y. M., Park I. K., Hahn H. G., Lee H. K., Kwon S. B., Jeong J. H., Yang S. J., Sohn U. D., Park K. C., A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells. Biological and Pharmaceutical Bulletin 2007 30 1 180 183 2-s2.0-33846088970 10.1248/bpb.30.180 (Pubitemid 46066343)
4. Hunt G., Todd C., Cresswell J. E., Thody A. J., α -Melanocyte stimulating hormone and its analogue Nle4DPhe7 α -MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. Journal of Cell Science 1994 107 1 205 211 2-s2.0-0028177933
5. Buscà R., Ballotti R., Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Research 2000 13 2 60 69 2-s2.0-0034127724 10.1034/j.1600-0749.2000.130203.x (Pubitemid 30324886)
6. Hasegawa K., Furuya R., Mizuno H., Umishio K., Suetsugu M., Sato K., Inhibitory effect of elephantopus mollis H.B. and K. Extract on melanogenesis in B16 murine melanoma cells by downregulating microphthalmia-associated transcription factor expression. Bioscience, Biotechnology and Biochemistry 2010 74 9 1908 1912 2-s2.0-77957373606 10.1271/bbb.100318
7. Saito H., Yasumoto K., Takeda K., Microphthalmia-associated transcription factor in the Wnt signaling pathway. Pigment Cell Research 2003 16 3 261 265 10.1034/j.1600-0749.2003.00039.x (Pubitemid 36597066)
8. Si L., Guo J., C-Kit-mutated melanomas: the Chinese experience. Current Opinion of Oncology 2013 25 2 160 165 10.1097/CCO.0b013e32835dafcc
9. Liu H. G., Kong M. X., Yao Q., Expression of Sox10 and c-Kit in sinonasal mucosal melanomas arising in the Chinese population. Head and Neck Pathology 2012 6 4 401 408 10.1007/s12105-012-0375-2
10. Thill M., Berna M. J., Grierson R., Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Research 2011 21 5 405 416 10.1097/CMR.0b013e328348db10
11. Allegra E., Trapasso S., Cancer stem cells in head and neck cancer. Onco Targets and Therapy 2012 5 375 383
12. Pietra G., Manzini C., Vitale M., Balsamo M., Ognio E., Boitano M., Queirolo P., Moretta L., Mingari M. C., Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. International Immunology 2009 21 7 793 801 2-s2.0-67649864077 10.1093/intimm/dxp047
13. Klein W. M., Wu B. P., Zhao S., Increased expression of stem cell markers in malignant melanoma. Modern Pathology 2007 20 1 102 107 10.1038/modpathol. 3800720 (Pubitemid 44967955)
14. Bell R. E., Levy C., The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Pigment Cell & MelaNoma Research 2011 24 6 1088 1106
15. Fang D., Nguyen T. K., Leishear K., Finko R., Kulp A. N., Hotz S., Van Belle P. A., Xu X., Elder D. E., Herlyn M., A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 2005 65 20 9328 9337 2-s2.0-27144557960 10.1158/0008-5472.CAN-05-1343 (Pubitemid 41508000)
16. Kusunoki S., Kato K., Tabu K., The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecologic Oncology 2013 129 3 598 605 10.1016/j.ygyno.2013.03.005
17. Hu F. W., Tsai L. L., Yu C. H., Chen P. N., Chou M. Y., Yu C. C., Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Molecular Nutrition & Food Research 2012 56 8 1247 1258
18. Purdue M. P., Freeman L. E. B., Anderson W. F., Tucker M. A., Recent trends in incidence of cutaneous melanoma among US caucasian young adults. Journal of Investigative Dermatology 2008 128 12 2905 2908 2-s2.0-57349094378 10.1038/jid.2008.159
19. Lee S. K., Zhang W., Sanderson B. J. S., Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. Journal of Agricultural and Food Chemistry 2008 56 16 7572 7577 2-s2.0-51649115109 10.1021/jf801014p
20. Chen B. Y., Kuo C. H., Liu Y. C., Ye L. Y., Chen J. H., Shieh C. J., Ultrasonic-assisted extraction of the botanical dietary supplement resveratrol and other constituents of Polygonum cuspidatum. Journal of Natural Products 2012 75 10 1810 1813 10.1021/np300392n
21. Blumenberg M., SKINOMICS: transcriptional profiling in dermatology and skin biology. Current Genomics 2012 13 5 363 368 10.2174/138920212801619241
22. Hocker T. L., Singh M. K., Tsao H., Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside. Journal of Investigative Dermatology 2008 128 11 2575 2595 2-s2.0-53949103143 10.1038/jid.2008.226
23. Satooka H., Kubo I., Resveratrol as a kcat type inhibitor for tyrosinase: potentiated melanogenesis inhibitor. Bioorganic and Medicinal Chemistry 2012 20 2 1090 1099 10.1016/j.bmc.2011.11.030
24. Lin C. B., Babiarz L., Liebel F., Price E. R., Kizoulis M., Gendimenico G. J., Fisher D. E., Seiberg M., Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. Journal of Investigative Dermatology 2002 119 6 1330 1340 2-s2.0-0036915855 10.1046/j.1523-1747.2002.19615.x (Pubitemid 36005617)
25. Larue L., Delmas V., The WNT/beta-catenin pathway in melanoma. Frontiers in Bioscience 2006 11 1 733 742 2-s2.0-32944460267 10.2741/1831 (Pubitemid 43258176)
26. Dorsky R. I., Moon R. T., Raible D. W., Control of neural crest cell fate by the Wnt signalling pathway. Nature 1998 396 6709 370 72 2-s2.0-0032569852 10.1038/24620 (Pubitemid 28557397)
27. Pilloni L., Bianco P., Difelice E., The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions. European Journal of Histochemistry 2011 55 2 e20
28. Kłosowska-Wardga A., Hasumi Y., Åhgren A., Heldin C. H., Hellberg C., Combination therapy using imatinib and vatalanib improves the therapeutic efficiency of paclitaxel towards a mouse melanoma tumor. Melanoma Research 2011 21 1 57 65 2-s2.0-79952770545 10.1097/CMR.0b013e32833faf4d
29. Cheli Y., Guiliano S., Botton T., Rocchi S., Hofman V., Hofman P., Bahadoran P., Bertolotto C., Ballotti R., Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 2011 30 20 2307 2318 2-s2.0-79956131573 10.1038/onc.2010.598
30. Guan H., Singh N. P., Singh U. P., Nagarkatti P. S., Nagarkatti M., Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PLoS One 2012 7 4 e35650
31. Liao H. F., Su Y. C., Zheng Z. Y., Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomedicine & Pharmacotherapy 2012 66 5 378 383
32. Su Y. C., Li S. C., Wu Y. C., Resveratrol downregulates interleukin-6-stimulated sonic hedgehog signaling in human acute myeloid leukemia. Evidence-Based Complementary and Alternative Medicine 2013 2013 11 547430 10.1155/2013/547430
33. Pandey P. R., Okuda H., Watabe M., Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Research and Treatment 2011 130 2 387 398 10.1007/s10549-010-1300-6
34. Yang Y. P., Chang Y. L., Huang P. I., Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. Journal of Cellular Physiology 2012 227 3 976 993 10.1002/jcp.22806
35. Shankar S., Nall D., Tang S. N., Meeker D., Passarini J., Sharma J., Srivastava R. K., Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 2011 6 1 2-s2.0-79551617718 10.1371/journal.pone.0016530 e16530